Shetty Ajit
Insider CIK 1667471 · AGRX Director · ATNM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-09-02 | 2026-09-04 | 92,400 | — | $0 | 92,400 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-09-02 | 2026-09-04 | 61,600 | — | $0 | 62,357 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-09-02 | 2026-09-04 | 92,400 | — | $0 | 92,400 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-09-02 | 2026-09-04 | 61,600 | — | $0 | 62,357 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 72,156 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 70,311 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 8,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 8,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 18,351 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2023-12-28 | 2023-12-29 | 70,311 | — | $0 | 70,311 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2022-07-01 | 2022-07-01 | 72,156 | — | $0 | 72,156 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2022-06-09 | 2022-06-10 | 807 | — | $0 | 807 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award | 2022-06-09 | 2022-06-10 | 670 | — | $0 | 2,241 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2021-09-01 | 2021-09-03 | 18,351 | — | $0 | 18,351 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2021-06-08 | 2021-06-10 | 29,905 | — | $0 | 29,905 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award | 2021-06-08 | 2021-06-10 | 24,510 | — | $0 | 62,852 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2020-08-12 | 2020-08-14 | 8,333 | — | $0 | 8,333 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2020-06-09 | 2020-06-11 | 22,606 | — | $0 | 22,606 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award | 2020-06-09 | 2020-06-11 | 13,393 | — | $0 | 38,342 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2019-07-12 | 2019-07-16 | 250,000 | $0.23 | $57.5K | 250,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2019-06-06 | 2019-06-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2018-07-13 | 2018-07-17 | 75,000 | $0.78 | $58.5K | 75,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise deriv | 2018-06-08 | 2018-06-08 | 17,949 | — | $0 | 0 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise | 2018-06-08 | 2018-06-08 | 17,949 | — | $0 | 24,949 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2018-06-07 | 2018-06-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2018-02-28 | 2018-03-01 | 22,730 | $0.43 | $9.8K | 22,730 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise | 2017-06-12 | 2017-06-14 | 7,000 | $3.75 | $26.3K | 7,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2017-06-08 | 2017-06-09 | 17,949 | — | $0 | 17,949 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2017-06-08 | 2017-06-09 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2016-06-08 | 2016-06-09 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2016-02-24 | 2016-02-24 | 21,000 | — | $0 | 21,000 | SEC↗ |